InvestorsHub Logo

Rdunn88

07/24/18 12:48 AM

#235173 RE: BonelessCat #235172

Lame excuse as competition exists for all drugs current and in development. Leo made a mistake by hyping Absssi and then shutting it down. Couldn’t find a partner to take on Merck.

Amatuer17

07/24/18 5:52 AM

#235177 RE: BonelessCat #235172

Interesting view - I have read your flowey views of B-Abssi and possibility of early approval without confirmatory study and how it can beat cubist deal and great advantage of single dose.

Have those evaporated in crowded market?